Post Reply
1-20 of 65
Singapore Paincare Holdings expects net loss for 1HFY2026
Singapore Paincare Holdings is expecting to report a net loss for its upcoming results for the 1HFY2026 ended Dec 31, 2025, reversing from a net profit the year before.
The net loss is attributed to lower revenue and other income and made worse by higher expenses incurred during the six months.
On Feb 3, the company announced that its 51%-owned subsidiary, Dermatology & Laser Specialist Clinic Pte. Ltd., had applied to be wound up pursuant to Section 161(1)(b) of the Insolvency, Restructuring and Dissolution Act 2018.
Tan Wei Cheong and Lim Loo Khoon of Deloitte Singapore SR& T Restructuring Services Pte Ltd, were appointed as the subsidiary&rsquo s joint and several provisional liquidators on Feb 2, after the filing of the statutory declaration and the directors&rsquo declaration that Dermatology & Laser Specialist Clinic was unable to continue its business.
An extraordinary general meeting (EGM) of Dermatology & Laser Specialist Clinic&rsquo s members and a meeting with its creditors will be convened in due course.
The liquidation is not expected to have a material impact on Singapore Paincare Holdings&rsquo net tangible assets (NTA) or earnings per share (EPS) for the current financial year.
On Feb 2, Singapore Paincare Holdings announced that its wholly-owned subsidiary, Singapore Paincare Center @ Novena Pte. Ltd, has leased 775 sq ft unit at #07-33 Mount Elizabeth Novena Specialist Centre for 24 months.
The tenancy agreement was signed with Medbridge Marketing, which is 100%-owned by Singapore Paincare Holdings&rsquo executive chairman, CEO and controlling shareholder, Dr Lee Mun Kam Bernard, making this an interested person transaction (IPT) under the listing rules.
The rental fees will come up to around $547,200, which represents 8.1% of Singapore Paincare Holdings&rsquo latest audited NTA of $6.8 million as at June 30, 2025.
The lease will commence on Feb 1.
Singapore Paincare Holdings will release its results on or before Feb 13.
Shares in Singapore Paincare Holdings closed 0.5 cents lower or 4.35% down at 11 cents on Feb 5.
Sias calls on Singapore Paincare to clarify actions after failed privatisation bid
Move is in light of the impact the collapsed deal has on minority shareholders
[SINGAPORE] The Securities Investors Association (Singapore), or Sias, called on medical services company Singapore Paincare to clarify its actions after its privatisation bid failed earlier this month.
The move is in light of the impact the collapsed deal has on minority shareholders and Sias called on the board of directors of Singapore Paincare to provide greater clarity and transparency.
The association referred to the lack of &ldquo available assets, funds or collateral&rdquo from the offeror, Advance Bridge Healthcare, to support a fresh financial resources confirmation.
The company in May offered to take the Catalist-listed Singapore Paincare private at S$0.16 per share &ndash a premium of 27 per cent over its last traded price then, but below its 2020 initial public offering price of S$0.22 per share.
The deal drew unwanted attention in August this year, when Sias flagged breaches of the Code on Take-overs and Mergers, after Singapore Paincare shareholders received WhatsApp messages signed by its CEO Dr Bernard Lee and chief operating officer Dr Jeffrey Loh before a privatisaton vote.
The pact collapsed on Dec 5 as credit facilities between Advance Bridge Healthcare &ndash a management consultancy for healthcare services &ndash and UOB lapsed after Nov 27.
The cut-off date to satisfy the scheme conditions was not extended, as Advance Bridge Healthcare also did not expect that it would be able to secure alternative sources of funding to do so.
Five key queries from Sias
Sias asked for &ldquo concrete steps&rdquo taken since Aug 27, as well as details on whether the offeror made &ldquo reasonable effort&rdquo and explored &ldquo all viable options&rdquo to reconvene the adjourned meeting and/or try to extend the expiry of the scheme to allow shareholders to vote on it.
Sias also questioned if the Singapore Paincare board was aware that the credit facilities agreement was going to lapse after Nov 27, given that Advance Bridge Healthcare in May had said that it had sufficient financial resources.
The takeovers and mergers communications breach was also brought up. Sias queried if the Singapore Paincare board investigated any potential breaches beyond the WhatsApp messages and if any follow-up actions were required with relevant authorities.
It also asked for updates on Singapore Paincare&rsquo s strategic direction and prospects. A question was highlighted on how the company&rsquo s board will &ldquo reconcile the forward-looking statements&rdquo in its recently released annual report with its &ldquo communications to shareholders over the past year&rdquo and during the now-lapsed offer.
&ldquo Sias is concerned that the circumstances surrounding the lapse of the offer may set an undesirable precedent for the conduct of takeovers and schemes of arrangement,&rdquo it said.
&ldquo Transparency, accountability and the fair and equal treatment of shareholders are fundamental principles of the Take-over Code and good corporate governance.&rdquo
Their recent few weeks moves including the financial result doesn't help them achieve the intended result so now they are trying to make the stock as "boring" as possible.
Halt or no halt trading is the same , almost whole day no one trading ....waiting for better offer ?
No money no bank backing cannot take over scheme. SIAS don't keep quiet give some noises hor..
Halt and suspension so many days later come out no take over scheme maybe no money and expired the funding by bank......SIAS please say something how to protect our minority SH ?
They already said volunteering suspension till they finalised the scheme but why take so long hope it can give a good money take over scheme : SIAS please watch over them.
bechaotic ( Date: 05-Dec-2025 09:53) Posted:
|
Company said SGX has granted them extension of up to yesterday 8.30 am to announce and to lift the suspension. And today already 5 Dec still no news?
For so long no forumer want to heed this stock no wonder owner want to keep it.
ysh2006 ( Date: 04-Dec-2025 13:02) Posted:
|
What type of sheme arrangement announcement ? hope it will give a better offer ...
This company so secretive cannot announce the scheme refer on 28 May and request for trading suspension ? SIAS please keep eyes on this stock for us....
SIAS please to see the new sheme tomorrow announce is it good for we all retail investors don' t take us for ride....
Tomorrow D day see whether this scheme of arrangement is it better than May or not, SIAS verify please..
Why no forumer interested this stock and SIAS fight hard for it for what ? should let it take over in May at 16c loh...
If the scheme are so so why take so long to announce ?scare SIAS to verify again ?
Maybe the scheme not so interested the same 16c ?that is why no one interested? SIAS no power to change it ?
SIAS tried hard to ask company to review the take over price , this news seem no former interested ?
A scheme dated on 28/5/25 will be nnounced by Thursday.....hope it is a good one !
Still no announcement ,anybody guess what news ?
ysh2006 ( Date: 28-Nov-2025 15:03) Posted:
|
So Monday share suspension if still no announcement ?